Do hepatitis B virus carriers develop atopic diseases?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 56, Issue 11, 2001, Pages 1100-1101

  Kocabas, Can Naci ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Atopic diseases; Hepatitis B virus carriers

Indexed keywords

ALLERGY; ARTICLE; ATOPY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; HEPATITIS A; HEPATITIS B VIRUS; IMMUNITY; MEASLES; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TH2 CELL; TUBERCULOSIS; VIRUS CARRIER; VIRUS REPLICATION;

CARRIER STATE; HEPATITIS B; HUMANS; HYPERSENSITIVITY, IMMEDIATE;

EID: 0034748963     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2001.00377.x     Document Type: Article

References (19)

1. Functional diversity of helper T lymphocytes
2. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon?
3. Interferon-γ production by cord-blood mononuclear cells is reduced in newborns with a family history of atopic disease and is independent from cord blood IgE levels
4. The causes of the increasing prevalence of allergy: Is atopy a microbial deprivation disorder?
5. The environment and sensitisation to allergens in early childhood
6. Reduced T cell function in atopic children
7. Measles and atopy in Guinea-Bissau
8. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus
9. The inverse association between tuberculin responses and atopic disorders
10. H2-dominant immunity in mice
11. Immunologic basis for chronicity of hepatitis B virus infection in neonates
12. Natural killer T cell activation inhibits hepatitis B virus replication in vivo
13. Activation-induced cell death in peripheral blood cells (PBMCs) from patients with chronic hepatitis B may be related to abnormal production of interleukin 12 and 10
14. Studies of interleukin-12 in chronic hepatitis B virus infection
15. Influence of T-helper cell subsets and crossregulation in hepatitis B virus infection
16. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: Vaccine-induced activation of antigen presenting dentritic cells
17. A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B
18. Interleukin-12: Potential clinical applications in the treatment of chronic viral hepatitis
19. Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection